Literature DB >> 28333388

Central Regulation of Glucose Homeostasis.

Alexander Tups1,2, Jonas Benzler2, Domenico Sergi3, Sharon R Ladyman4, Lynda M Williams3.   

Abstract

The ability of the brain to directly control glucose levels in the blood independently of its effects on food intake and body weight has been known ever since 1854 when Claude Bernard, a French physiologist, discovered that lesioning the floor of the fourth ventricle in rabbits led to a rise of sugar in the blood. Despite this outstanding discovery at that time, it took more than 140 years before progress started to be made in identifying the underlying mechanisms of brain-mediated control of glucose homeostasis. Technological advances including the generation of brain insulin receptor null mice revealed that insulin action specifically in the central nervous system is required for the regulation of glucose metabolism, particularly in the modulation of hepatic glucose production. Furthermore, it was established that the hormone leptin, known for its role in regulating food intake and body weight, actually exerts its most potent effects on glucose metabolism, and that this function of leptin is mediated centrally. Under certain circumstances, high levels of leptin can replicate the actions of insulin, thus challenging the idea that life without insulin is impossible. Disruptions of central insulin signaling and glucose metabolism not only lead to impairments in whole body glucose homeostasis, they also have other serious consequences, including the development of Alzheimer's disease which is sometimes referred to as type 3 diabetes reflecting its common etiology with type 2 diabetes. © 2017 American Physiological Society. Compr Physiol 7:471-764, 2017.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28333388     DOI: 10.1002/cphy.c160015

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  19 in total

Review 1.  Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.

Authors:  Pads Palihaderu; Bilm Mendis; Jmkjk Premarathne; Wkrr Dias; Swee Keong Yeap; Wan Yong Ho; A S Dissanayake; I H Rajapakse; P Karunanayake; U Senarath; D A Satharasinghe
Journal:  Epigenet Insights       Date:  2022-10-15

2.  Mitochondria-Bound Hexokinase (mt-HK) Activity Differ in Cortical and Hypothalamic Synaptosomes: Differential Role of mt-HK in H2O2 Depuration.

Authors:  João Paulo Cavalcanti-de-Albuquerque; Eduardo de Souza Ferreira; Denise Pires de Carvalho; Antonio Galina
Journal:  Mol Neurobiol       Date:  2017-11-08       Impact factor: 5.590

Review 3.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

Review 4.  Central actions of insulin during pregnancy and lactation.

Authors:  Sharon R Ladyman; Virginia L Brooks
Journal:  J Neuroendocrinol       Date:  2021-03-12       Impact factor: 3.870

5.  SerpinA3N is a novel hypothalamic gene upregulated by a high-fat diet and leptin in mice.

Authors:  Domenico Sergi; Fiona M Campbell; Christine Grant; Amanda C Morris; Eva-Maria Bachmair; Christiane Koch; Fiona H McLean; Aifric Muller; Nigel Hoggard; Baukje de Roos; Begona Porteiro; Mark V Boekschoten; Fiona C McGillicuddy; Darcy Kahn; Phyllis Nicol; Jonas Benzler; Claus-Dieter Mayer; Janice E Drew; Helen M Roche; Michael Muller; Ruben Nogueiras; Carlos Dieguez; Alexander Tups; Lynda M Williams
Journal:  Genes Nutr       Date:  2018-11-29       Impact factor: 5.523

6.  Effects of dietary restriction on neuroinflammation in neurodegenerative diseases.

Authors:  Luigi Fontana; Laura Ghezzi; Anne H Cross; Laura Piccio
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

7.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

8.  Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.

Authors:  Domenico Sergi; Justine Renaud; Nicola Simola; Maria-Grazia Martinoli
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

9.  RIPC provides neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway.

Authors:  Jing Lv; Weikang Guan; Qiang You; Li Deng; Yan Zhu; Kan Guo; Xiaoqing Gao; Jiming Kong; Chaoxian Yang
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

10.  Reducing Glut2 throughout the body does not result in cognitive behaviour differences in aged male mice.

Authors:  Nicola Morrice; Lidy van Aalten; Alison McNeilly; Rory J McCrimmon; Ewan R Pearson; Rosamund Langston; Calum Sutherland
Journal:  BMC Res Notes       Date:  2020-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.